Sysnav Healthcare Team was honored to present promising results during the 2022 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) back in October.

The event was filled with learnings and insights related to existing and future disease-modifying therapies to improve the lives of people with Multiple Sclerosis.

This event reinforced Sysnav’s commitment to make a positive contribution in the field, by providing meaningful digital endpoints on patient mobility based on real-world data.

Here is a snapshot of our promising analytical & external validation work presented during ECTRIMS 2022 on patients’ gait characteristics, measured by the Syde device.